Brit J Cancer: The Relationship between Diabetes and Prostate Cancer Risk
-
Last Update: 2020-06-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In a recent study published in the journal British Journal of Cancer, the journal of the field of oncology, researchers looked forward to assessing the link between diabetes and prostate cancer risk determined by clinical and molecular characteristicsfrom 1986 to 2014, a total of 49,392 male subjects from the Health Professional Follow-up Study (HPFS) were followedAt baseline, the researchers collected self-reported diabetes data from subjects and updated them every two yearsClinical characteristics of prostate cancer include local, late, fatal, low, moderate and highMolecular features include TMPRSS2:ERG and PTEN subtypesThe researchers used the Cox proportional risk regression model to assess the association between diabetes and the incidence of subtype-specific prostate cancerin a 28-year follow-up, researchers recorded 6,733 cases of prostate cancerCompared to men without diabetes, the overall risk of diabetes (HR 0.82, 95% CI is 0.75-0.90), local (HR 0.82, 95% CI is 0.74-0.92), low-level and moderate prostate cancer (HR 0.77, 95% CI is 0.66-0.90; HR is 0.77,95%.05.05.91)For molecular subtypes, HRs in ERG-negative and ERG-positive cases were 0.63 (0.42-0.95) and 0.72 (0.46-1.12), respectively, and 0.69 (0.48-0.98) and 0.52 (0.19-1.41) for PTEN full cases and PTEN missing cases, respectively, the study is the first to report a link between diabetes and ERG/PTEN prostate cancer, in addition to providing further evidence of a negative link between diabetes and prostate cancer
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.